Clinical experiences of the infections caused by extended-spectrum β-lactamase-producing Serratia marcescens at a Medical Center in Taiwan

Japanese Journal of Infectious Diseases

Volumn 59, Issue 3, 2006, Pages 147-152

  Cheng, Kuo Chen ^a   Chuang, Yin Ching ^a   Wu, Lii Tzu ^b   Huang, Guan Cheng ^a   Yu, Wen Liang ^a,c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFRADINE; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLOMOXEF; GENTAMICIN; IMIPENEM; PIPERACILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISEASE SEVERITY; GRAM NEGATIVE INFECTION; HUMAN; INCIDENCE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PNEUMONIA; PYURIA; SERRATIA MARCESCENS; TAIWAN; TREATMENT FAILURE; URINARY TRACT INFECTION;

AMIKACIN; BETA-LACTAMASES; CARBAPENEMS; CEPHALOSPORINS; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SERRATIA INFECTIONS; SERRATIA MARCESCENS; TAIWAN;

EID: 33745481474     PISSN: 13446304     EISSN: 13446304     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yu, W. L., Lin, C. W. and Wang, D. Y. (1998): Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of isolates. J. Microbiol. Immunol. Infect., 31, 171-179.
2. Wu, L. T., Tsou, M. F., Wu, H. J., Chen, H. E., Chuang, Y. C. and Yu, W. L. (2004): Survey of CTX-M-3 extended-spectrum β-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan. Diagn. Microbiol. Infect. Dis., 49, 125-129.
3. Yu, W. L., Wu, L. T., Pfaller, M. A., Winokur, P. L. and Jones, R. N. (2003): Confirmation of extended-spectrum β-lactamase-producing Serratia marcescens: preliminary report from Taiwan. Diagn. Microbiol. Infect. Dis., 45, 221-224.
4. Paterson, D. L., Ko, W. C., Von Gottberg, A., et al. (2001): Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory J. Clin. Microbiol., 39, 2206-2212.
5. Paterson, D. L., Ko, W. C., Von Gottberg, A., et al. (2004): Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis., 39, 31-37.
6. National Committee for Clinical Laboratory Standards (2005): Performance standards for antimicrobial susceptibility testing. 15th Informational supplement M100-S15. MIC testing. National Committee for Clinical Laboratory Standards. Wayne, Pa.
7. National Committee for Clinical Laboratory Standards (2003): Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A8. National Committee for Clinical Laboratory Standards. Wayne, Pa.
8. National Committee for Clinical Laboratory Standards (2003): Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. National Committee for Clinical Laboratory Standards. Wayne, Pa.
9. Birnboim, H. C. and Doly, J. (1979): A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res., 7, 1513-1523.
10. Mabilat, C. and Goussard, S. (1993): PCR detection and identification of genes for extended-spectrum β-lactamases. p. 553-559. In Persing, D. H., Smith, T. F., Tenover, F. and White, T. J. (eds.), Diagnostic Molecular Microbiology: Principles and Application. American Society for Microbiology Press, Washington, D. C.
11. Kim, J., Kwon, Y., Pai, H., Kim, J. W. and Cho, D. T. (1998): Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol., 36, 1446-1449.
12. Yu, W. L., Winokur, P. L., Von Stein, D. L., Pfaller, M. A., Wang, J. H. and Jones, R. N. (2002): First description of Klebsiella pneumoniae harboring CTX-M β-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob. Agents Chemother., 46, 1098-1100.
13. Pfaller, M. A., Wendt, C., Hollis, R. J., Wenzel, R. P., Fritschel, S. J., Neubauer, J. J. and Herwaldt, L. A. (1996): Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diag. Microbiol. Infect. Dis., 25, 1-8.
14. Tenover, F. C., Arbeit, R. D. and Goering, R. V. (1997): How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect. Control Hosp. Epidemiol., 18, 426-439.
15. Naumiuk, L., Baraniak, A., Gniadkowski, M., Krawczyk, B., Rybak, B., Sadowy, E., Samet, A. and Kur, J. (2004): Molecular epidemiology of Serratia marcescens in two hospitals in Danzig, Poland, over a 5-year period. J. Clin. Microbiol., 42, 3108-3116.
16. De Champs, C., Chanal, C., Sirot, D., Baraduc, R., Romaszko, J. P., Bonnet, R., Plaidy, A., Boyer, M., Carroy, E., Gbadamassi, M. C., Laluque, S., Oules, O., Poupart, M. C., Villemain, M. and Sirot, J. (2004): Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J. Antimicrob. Chemother., 54, 634-639.
17. CTX-M genes. FEMS Microbiol. Lett., 234, 201-207.